Clinical trial Recruiting at 1 site Observational Ages 18 and up

National insurance funding to increase vaccination in outpatient care

Official title: "Assessment of the Impact of Vaccine Funding by the National Health Insurance on Vaccination Coverage Among Patients Targeted by Current Vaccination Recommendations and Followed in Outpatient Consultations in Ile-de-France Region in France""

Run by Assistance Publique - Hôpitaux de Paris · NCT07243236 · Data updated 2026-11-12

This project will try giving vaccines paid for by the national health insurance in outpatient visits at several hospitals to see if it raises pertussis vaccination in pregnant women and pneumococcal vaccination in eligible adults.

More Postpartum trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment2920 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations6 sites (Paris, IDF and 5 other locations)
StatusRecruiting
StartedNovember 19, 2025
Main results expectedMay 2027
Study endsJuly 2027
Registry record updatedApril 8, 2026
Trial IDNCT07243236 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are adults eligible for pneumococcal vaccination who attend outpatient consultations at participating institutions (and meet ALD/C2S/AME criteria) and pregnant women who had at least one outpatient follow‑up from 20 weeks gestation or are in the immediate postpartum stay at participating maternity wards.

Probably not a fit

Patients who are not eligible under the national immunization schedule, who do not attend the participating outpatient clinics, or who cannot be reached for follow‑up are unlikely to benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project follows patients seen in outpatient consultations at four health institutions in Île‑de‑France after a tripartite agreement enabled National Health Insurance funding of recommended vaccines administered on site. Data collection combines patient and provider questionnaires with vaccination records to measure coverage for pertussis in pregnancy and pneumococcal vaccination in eligible adults. Analyses will examine changes in coverage, the influence of socio‑economic factors, and whether hospital clinician practices and documentation of vaccination status change. If coverage improves during the funding period, investigators plan to present results to national health authorities to support broader agreements between hospitals and local insurers.

Why it matters

Potential benefit: If successful, the approach could raise vaccine uptake among vulnerable outpatients and support policy changes to reimburse vaccines given in hospitals.

How similar studies have gone: Similar in‑hospital and insurer‑supported vaccination programs have shown mixed but often positive effects on coverage in comparable settings, while broad national rollouts remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For patients:

1. For the assessment of pneumococcal coverage among patients eligible for this vaccination:

   * Individuals aged 18 years or older,
   * Individuals followed in outpatient consultations within a department and healthcare institution participating in the project;
   * Individuals eligible for pneumococcal vaccination against according to current French recommendations,
   * Individuals meeting the eligibility conditions and receiving care under long-term illness coverage (ALD) or benefiting from complementary universal health coverage (C2S) or state medical aid (AME).
2. For the assessment of pertussis vaccination among pregnant women:

   * Women aged 18 years or older,
   * Women who have had at least one follow-up outpatient consultation from 20 weeks of gestation in a maternity ward participating in the project,
   * Women in the immediate postpartum period (during their maternity stay) who have given birth to one or more live children and delivered after 36 weeks of gestation,
   * Women who have declared their pregnancy and are covered under maternity insurance (i.e., from the first day of the sixth month of pregnancy until the 12th day after delivery).

For healthcare professionals: all vaccinating healthcare providers working in a participating department or center.

Exclusion Criteria:

* Individuals seen in settings other than outpatient consultations (day hospital, week hospital, conventional hospitalization, International Vaccination Center).

Where it's running

  • COCHIN HOSPITAL - Assistance Publique-Hôpitaux de Paris (APHP)
    Paris, Idf, France
    Recruiting
  • Sud Seine Et Marne Hospital
    Fontainebleau, France
    Not yet recruiting
  • Sud Seine Et Marne Hospital
    Montereau-Fault-Yonne, France
    Not yet recruiting
  • Sud Seine Et Marne Hospital
    Nemours, France
    Not yet recruiting
  • Rambouillet Hospital
    Rambouillet, France
    Not yet recruiting
  • Delafontaine Hospital
    Saint-Denis, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.